Literature DB >> 26191190

MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.

Fenghua Liu1, Yukai He1, Ronghua Shu2, Sikui Wang1.   

Abstract

In this study, we suggested the level of miR-1297 was downreguled in the human hepatocellular carcinoma compared to the normal cells. We demonstrate ectopic expression of miR-1297 could significantly suppress hepatocellular carcinoma cells proliferation and enhance the cell apoptosis. In vitro reporter assay suggested EZH2 is a direct target gene of miR-1297. Furthermore, knockdown of EZH2 have the same effect with miR-1297 overeexpression in hepatocellular carcinoma cells. These findings provide evidence that miR-1297 plays a key role in inhibition of the hepatocellular carcinoma cells proliferation, and enhancing cell apoptosis through targeting EZH2, and strongly suggest that ex ogenous miR-1297 may have therapeutic value in treating hepatocellular carcinoma.

Entities:  

Keywords:  EZH2; hepatocellular carcinoma; miR-1297; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26191190      PMCID: PMC4503062     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

Authors:  Yasuko Matsukawa; Shuho Semba; Hirotaka Kato; Akihiko Ito; Kazuyoshi Yanagihara; Hiroshi Yokozaki
Journal:  Cancer Sci       Date:  2006-06       Impact factor: 6.716

2.  The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.

Authors:  Jianbiao Zhou; Chonglei Bi; Lip-Lee Cheong; Sylvia Mahara; Shaw-Cheng Liu; Kian-Ghee Tay; Tze-Loong Koh; Qiang Yu; Wee-Joo Chng
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

3.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

4.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

5.  Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.

Authors:  Daniela Holland; Karin Hoppe-Seyler; Bettina Schuller; Claudia Lohrey; Julia Maroldt; Matthias Dürst; Felix Hoppe-Seyler
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 6.  MicroRNAs in cholangiociliopathies.

Authors:  Tatyana Masyuk; Anatoliy Masyuk; Nicholas LaRusso
Journal:  Cell Cycle       Date:  2009-05-23       Impact factor: 4.534

7.  miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.

Authors:  Chao Zhang; Yong Liang Chi; Ping Yu Wang; Ya Qi Wang; Yan Xia Zhang; Jingti Deng; Chang Jun Lv; Shu Yang Xie
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

8.  Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.

Authors:  Irfan A Asangani; Paul W Harms; Lois Dodson; Mithil Pandhi; Lakshmi P Kunju; Christopher A Maher; Douglas R Fullen; Timothy M Johnson; Thomas J Giordano; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Oncotarget       Date:  2012-09

9.  Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.

Authors:  M E Gonzalez; X Li; K Toy; M DuPrie; A C Ventura; M Banerjee; M Ljungman; S D Merajver; C G Kleer
Journal:  Oncogene       Date:  2008-12-15       Impact factor: 9.867

10.  The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.

Authors:  J C Steele; E E Torr; K L Noakes; E Kalk; P A Moss; G M Reynolds; S G Hubscher; M van Lohuizen; D H Adams; L S Young
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640

View more
  7 in total

1.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

2.  Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro.

Authors:  Jiachong Wang; Xiaoyun Xu; Shaowei Mo; Ye Tian; Jian Wu; Jianning Zhang; Jiannong Zhao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

3.  Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.

Authors:  Qiwei Yang; Archana Laknaur; Lelyand Elam; Nahed Ismail; Larisa Gavrilova-Jordan; John Lue; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-03-31       Impact factor: 3.060

4.  Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation.

Authors:  Yang Xiaoling; Zhao Li; Li ShuQiang; Ma Shengchao; Yang Anning; Ding Ning; Li Nan; Jia Yuexia; Yang Xiaoming; Li Guizhong; Jiang Yideng
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease.

Authors:  Xin Luo; Sheng-Zheng Luo; Zi-Xin Xu; Cui Zhou; Zheng-Hong Li; Xiao-Yan Zhou; Ming-Yi Xu
Journal:  World J Gastroenterol       Date:  2021-04-14       Impact factor: 5.742

6.  Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors.

Authors:  Abbas Mosapour; Fatemeh Soghra Karami Tehrani; Morteza Atri
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

7.  Circular RNA hsa_Circ_101141 as a Competing Endogenous RNA Facilitates Tumorigenesis of Hepatocellular Carcinoma by Regulating miR-1297/ROCK1 Pathway.

Authors:  Tao Zhang; Lijuan Zhang; Dan Han; Kebinur Tursun; Xiaobo Lu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.